Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Receivables - Net: 2010-2025

Historic Receivables - Net for BIO-TECHNE (TECH) over the last 16 years, with Jun 2025 value amounting to $206.9 million.

  • BIO-TECHNE's Receivables - Net fell 17.79% to $183.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $183.9 million, marking a year-over-year decrease of 17.79%. This contributed to the annual value of $206.9 million for FY2025, which is 14.30% down from last year.
  • As of FY2025, BIO-TECHNE's Receivables - Net stood at $206.9 million, which was down 14.30% from $241.4 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Receivables - Net ranged from a high of $241.4 million in FY2024 and a low of $145.4 million during FY2021.
  • Over the past 3 years, BIO-TECHNE's median Receivables - Net value was $218.5 million (recorded in 2023), while the average stood at $222.2 million.
  • In the last 5 years, BIO-TECHNE's Receivables - Net skyrocketed by 33.82% in 2022 and then declined by 14.30% in 2025.
  • Yearly analysis of 5 years shows BIO-TECHNE's Receivables - Net stood at $145.4 million in 2021, then surged by 33.82% to $194.5 million in 2022, then rose by 12.30% to $218.5 million in 2023, then rose by 10.49% to $241.4 million in 2024, then declined by 14.30% to $206.9 million in 2025.